Bern, Switzerland

Thomas Cerny

This inventor holds 1 USPTO granted patent. Top assignee: Newcastle University Ventures Limited. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Cerny. Retrieved from https://idiyas.com/inventor/thomas-cerny-8fahotjo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Cerny: Innovator in Medical Treatments

Introduction

Thomas Cerny is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of medical treatments, particularly in addressing encephalopathy. His innovative approach has led to the development of a unique patent that showcases his expertise and dedication to improving healthcare.

Latest Patents

Thomas Cerny holds a patent for "Methylene blue for the treatment or prophylaxis of encephalopathy caused." This patent represents a significant advancement in the treatment options available for this condition. With 1 patent to his name, Cerny is making strides in the medical field.

Career Highlights

Cerny is associated with Newcastle University Ventures Limited, where he continues to work on innovative projects. His role at the company allows him to collaborate with other experts and contribute to groundbreaking research in medical treatments.

Collaborations

One of his notable collaborators is Adrian Kupfer. Together, they work on various projects that aim to enhance the understanding and treatment of medical conditions.

Conclusion

Thomas Cerny is a dedicated inventor whose work in medical treatments is paving the way for new solutions in healthcare. His contributions are vital in the ongoing quest to improve patient outcomes and advance medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…